New approaches to management of bleeding disorders.
Aledort
L M
LM
Department of Medicine, Mount Sinai School of Medicine, New York.
D000281:Administration, Intranasal; D000287:Administration, Topical; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D003894:Deamino Arginine Vasopressin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006474:Hemorrhagic Disorders / Q000628:therapy*; D006490:Hemostatics / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D008103:Liver Cirrhosis / Q000150:complications; D013514:Surgical Procedures, Operative; D014511:Uremia / Q000150:complications; D014842:von Willebrand Diseases / Q000188:drug therapy
D000933:Antifibrinolytic Agents; D006490:Hemostatics; D003894:Deamino Arginine Vasopressin